Annals of Surgical Oncology, Vol 2, Issue 6 537-541, Copyright © 1995 by Society of Surgical Oncology

ARTICLES

Improved survival after resection of colorectal liver metastases

G. M. Fuhrman, S. A. Curley, D. C. Hohn and M. S. Roh
Department of Surgery, Ochsner Clinic, New Orleans, Louisiana 70121, USA.

BACKGROUND: The goal of this study was to determine if staging with intraoperative ultrasound (IOUS), assessment of porta hepatis lymph nodes, and evaluation of resection margins can improve selection of patients likely to benefit from resection of colorectal liver metastases. METHODS: A retrospective evaluation was performed on patients undergoing celiotomy with intent to resect colorectal liver metastases. Patients were considered unresectable if extrahepatic disease was identified by peritoneal exploration or if IOUS demonstrated greater than four lesions or the inability to achieve negative margins. Tumor-negative margins were confirmed by pathologic evaluation. Actuarial 5-year survival was calculated using the method of Kaplan and Meier. RESULTS: Median follow-up is 25 months. Of the 151 patients undergoing operative exploration, 107 (71.0%) underwent liver resection (all margins tumor negative). Three operative deaths occurred in this group (2.8%). The disease of 30 patients (19.8%) was considered unresectable due to extrahepatic involvement, and that of 14 patients (9.2%) was demonstrated by IOUS to be unresectable. Five-year actuarial survival was 44% for the resected group and 0% for the unresectable patients (p < 0.0001). CONCLUSIONS: IOUS, portal node assessment, and pathologic margin evaluation improves the selection of patients likely to benefit from resection of colorectal liver metastases.

This article has been cited by other articles:

				J. J. Bennett, C. R. Schmidt, D. S. Klimstra, S. R. Grobmyer, N. M. Ishill, M. D'Angelica, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and W. R. Jarnagin Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases Ann. Surg. Oncol., April 1, 2008; 15(4): 1130 - 1136. [Abstract] [Full Text] [PDF]

				C. Charnsangavej, B. Clary, Y. Fong, A. Grothey, T. M. Pawlik, and M. A. Choti Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement Ann. Surg. Oncol., October 1, 2006; 13(10): 1261 - 1268. [Full Text] [PDF]

				G. Vlastos, D. L. Smith, S. E. Singletary, N. Q. Mirza, T. M. Tuttle, R. J. Popat, S. A. Curley, L. M. Ellis, M. S. Roh, and J.-N. Vauthey Long-term Survival After An Aggressive Surgical Approach in Patients With Breast Cancer Hepatic Metastases Ann. Surg. Oncol., September 1, 2004; 11(9): 869 - 874. [Abstract] [Full Text] [PDF]

				C. L. Scaife, S. A. Curley, F. Izzo, P. Marra, P. Delrio, B. Daniele, F. Cremona, J. E. Gershenwald, J. L. Chase, R. D. Lozano, et al. Feasibility of Adjuvant Hepatic Arterial Infusion of Chemotherapy After Radiofrequency Ablation With or Without Resection in Patients With Hepatic Metastases From Colorectal Cancer Ann. Surg. Oncol., May 1, 2003; 10(4): 348 - 354. [Abstract] [Full Text] [PDF]

				I. A. Zealley, S. J. Skehan, J. Rawlinson, G. Coates, C. Nahmias, and S. Somers Selection of Patients for Resection of Hepatic Metastases: Improved Detection of Extrahepatic Disease with FDG PET RadioGraphics, October 1, 2001; 21(90001): S55 - 69. [Abstract] [Full Text] [PDF]